|
|
| Line 1: |
Line 1: |
| == Idiopathic inflammatory myopathies == | | ==Acid Base Disorders== |
| * There are several types of idiopathic inflammatory myopathies which include:<ref name="pmid29595280">{{cite journal |vauthors=Vencovský J |title=[Idiopathic inflammatory myopathies] |language=Czech |journal=Vnitr Lek |volume=64 |issue=2 |pages=155–163 |date=2018 |pmid=29595280 |doi= |url=}}</ref><ref name="pmid29579414">{{cite journal |vauthors=Adler BL, Christopher-Stine L |title=Triggers of inflammatory myopathy: insights into pathogenesis |journal=Discov Med |volume=25 |issue=136 |pages=75–83 |date=February 2018 |pmid=29579414 |doi= |url=}}</ref><ref name="pmid25182203">{{cite journal |vauthors=Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Szöllősi L, Dankó K |title=Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort |journal=Autoimmun Rev |volume=13 |issue=12 |pages=1211–9 |date=December 2014 |pmid=25182203 |doi=10.1016/j.autrev.2014.08.011 |url=}}</ref><ref name="BohanPeter1975">{{cite journal|last1=Bohan|first1=Anthony|last2=Peter|first2=James B.|title=Polymyositis and Dermatomyositis|journal=New England Journal of Medicine|volume=292|issue=8|year=1975|pages=403–407|issn=0028-4793|doi=10.1056/NEJM197502202920807}}</ref><ref name="pmid26429706">{{cite journal |vauthors=Tiniakou E, Mammen AL |title=Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review |journal=Clin Rev Allergy Immunol |volume=52 |issue=1 |pages=20–33 |date=February 2017 |pmid=26429706 |doi=10.1007/s12016-015-8511-x |url=}}</ref><ref name="pmid24305450">{{cite journal |vauthors=Amato AA, Greenberg SA |title=Inflammatory myopathies |journal=Continuum (Minneap Minn) |volume=19 |issue=6 Muscle Disease |pages=1615–33 |date=December 2013 |pmid=24305450 |doi=10.1212/01.CON.0000440662.26427.bd |url=}}</ref><ref name="pmid19349710">{{cite journal |vauthors=Dimachkie MM, Barohn RJ |title=Idiopathic inflammatory myopathies |journal=Front Neurol Neurosci |volume=26 |issue= |pages=126–46 |date=2009 |pmid=19349710 |doi=10.1159/000212374 |url=}}</ref><ref name="pmid18351525">{{cite journal |vauthors=Greenberg SA |title=Inflammatory myopathies: evaluation and management |journal=Semin Neurol |volume=28 |issue=2 |pages=241–9 |date=April 2008 |pmid=18351525 |doi=10.1055/s-2008-1062267 |url=}}</ref><ref name="pmid21444016">{{cite journal |vauthors=Khan S, Christopher-Stine L |title=Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features |journal=Rheum. Dis. Clin. North Am. |volume=37 |issue=2 |pages=143–58, v |date=May 2011 |pmid=21444016 |doi=10.1016/j.rdc.2011.01.001 |url=}}</ref><ref name="pmid21411269">{{cite journal |vauthors=Dalakas MC |title=Pathophysiology of inflammatory and autoimmune myopathies |journal=Presse Med |volume=40 |issue=4 Pt 2 |pages=e237–47 |date=April 2011 |pmid=21411269 |doi=10.1016/j.lpm.2011.01.005 |url=}}</ref><ref name="Hilton-Jones2011">{{cite journal|last1=Hilton-Jones|first1=David|title=Observations on the classification of the inflammatory myopathies|journal=La Presse Médicale|volume=40|issue=4|year=2011|pages=e199–e208|issn=07554982|doi=10.1016/j.lpm.2010.10.035}}</ref><ref name="BenvenisteLéger2011">{{cite journal|last1=Benveniste|first1=Olivier|last2=Léger|first2=Jean-Marc|title=Inflammatory or necrotizing myopathies, myositides and other acquired myopathies, new insight in 2011|journal=La Presse Médicale|volume=40|issue=4|year=2011|pages=e197–e198|issn=07554982|doi=10.1016/j.lpm.2011.02.002}}</ref><ref name="pmid12913190">{{cite journal |vauthors=van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, de Visser M |title=Polymyositis: an overdiagnosed entity |journal=Neurology |volume=61 |issue=3 |pages=316–21 |date=August 2003 |pmid=12913190 |doi= |url=}}</ref><ref name="pmid14501840">{{cite journal |vauthors=Amato AA, Griggs RC |title=Treatment of idiopathic inflammatory myopathies |journal=Curr. Opin. Neurol. |volume=16 |issue=5 |pages=569–75 |date=October 2003 |pmid=14501840 |doi=10.1097/01.wco.0000093099.34793.40 |url=}}</ref><ref name="pmid16769649">{{cite journal |vauthors=Briani C, Doria A, Sarzi-Puttini P, Dalakas MC |title=Update on idiopathic inflammatory myopathies |journal=Autoimmunity |volume=39 |issue=3 |pages=161–70 |date=May 2006 |pmid=16769649 |doi=10.1080/08916930600622132 |url=}}</ref><ref name="DalakasHohlfeld2003">{{cite journal|last1=Dalakas|first1=Marinos C|last2=Hohlfeld|first2=Reinhard|title=Polymyositis and dermatomyositis|journal=The Lancet|volume=362|issue=9388|year=2003|pages=971–982|issn=01406736|doi=10.1016/S0140-6736(03)14368-1}}</ref>
| |
| * Similar features are:
| |
| ** Symmetrical, proximal muscle weakness
| |
| ** Elevated muscle enzymes
| |
| ** Elevated myoglobin
| |
| ** Increased risk of malignancies
| |
| ** Abnormal electrical properties of muscle fibers detected by EMG
| |
| ** Positive autoantibodies against nuclear or cytoplasmic antigens in their serum
| |
| ** Treatment with glucocorticoids and immunosuppressive drugs
| |
| {| class="wikitable"
| |
| !Inflammatory myopathy
| |
| !
| |
| !
| |
| !
| |
| |-
| |
| |Polymyositis and dermatomyositis
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Inclusion body myositis<ref name="pmid8871577">{{cite journal |vauthors=Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ |title=Inclusion body myositis: clinical and pathological boundaries |journal=Ann. Neurol. |volume=40 |issue=4 |pages=581–6 |date=October 1996 |pmid=8871577 |doi=10.1002/ana.410400407 |url=}}</ref>
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Immune mediated necrotizing myopathy
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Juvenile myositis
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Cancer associated myositis
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Myositis in overlap syndromes
| |
| |
| |
| |
| |
| |
| |
| |}
| |
| | |
| ==References==
| |
| {{reflist}}
| |